Skip to main content
Premium Trial:

Request an Annual Quote

Complete Genomics Registers $7M in Employee Stock Options

NEW YORK (GenomeWeb News) – Complete Genomics has filed for the registration of up to $7 million in additional shares in connection to a stock option being offered to employees.

In a document filed with the US Securities and Exchange Commission on Monday, the Mountain View, Calif.-based sequencing services firm registered about 1.6 million shares of its common stock at a proposed maximum offering price of $4.53 per share.

The offering price was based on the average of the high and low prices of Complete Genomics' stock on Nov. 9.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.